Pro-Pharmaceuticals
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(617) 559-0033Website
www.pro-pharmaceuticals.comRevenue
$22.7 MillionIndustry
About Pro-Pharmaceuticals
Pro-Pharmaceuticals, Inc. specializes in developing innovative cancer therapies, particularly through its carbohydrate linker technology designed to enhance existing anti-cancer agents. The company is actively involved in clinical trials, including Phase I studies of its product DAVANAT for various solid tumors. Its intended clients primarily include cancer patients and healthcare institutions engaged in oncology. Pro-Pharmaceuticals also emphasizes collaboration with experts in carbohydrate chemistry and clinical development to advance its research and product offerings.Explore more
SIC Code 28,283NAICS Code 32,325Show morePro-Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Pro-Pharmaceuticals
Compare insights from companies similar to Pro-Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$13.5M
51-200
Private
-
2019
Kristin PolsenskiVice President, Portfolio & Program & Alliance Management To The Chief of Staff & CEO
Pro-Pharmaceuticals Tech Stack
A closer look at the technologies used by Pro-Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pro-Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Pro-Pharmaceuticals, Inc. specializes in developing innovative cancer therapies, particularly through its carbohydrate linker technology designed to enhance existing anti-cancer agents. The company is actively involved in clinical trials, including Phase I studies of its product DAVANAT for various solid tumors. Its intended clients primarily inclu... Read More
